VRCIVerici Dx plc
0.2250GBP0.00%Mkt Cap: 6.60M $P/E:

Verici Dx plc, together with its subsidiary, Verici Dx Inc, develops prognostic and diagnostic tests for kidney transplant patients in the United Kingdom and the United States. The company develops Tutivia, a post-transp…

HeadlineSourceTime
Today
DirectorsTalk Interviews
This week
DirectorsTalk Interviews
Older
DirectorsTalk Interviews
marketscreener.com
Proactive financial news
VVox Markets
Proactive Investors
Yahoo Finance UK
DirectorsTalk Interviews
Kalkine Media
TThe National Law Review
TradingView
DirectorsTalk Interviews
DirectorsTalk Interviews
TradingView
TradingView
Business Wire
Business Wire
Investing.com UK
DirectorsTalk Interviews